Dive Into Relatiant’s Dash Innovative Solutions For Enduring Challenges In Healthcare

 

 

Navigating the labyrinthine world of healthcare can be daunting, with the challenges in healthcare presenting both patients and providers with numerous hurdles. However, imagine a world where these challenges are significantly reduced; where seeing your doctor isn’t an exercise in patience, making payments is straightforward, and the concept of a ‘digital front door’ for healthcare isn’t a far-off dream but a reality.

This is the world that Dash, a healthcare platform, aims to create. Focusing on breaking down the barriers of confusion and complexity, Dash is all set to revolutionize healthcare accessibility. The future is indeed bright for Dash with its potential to scale, transform patient access, and bring unprecedented changes.

David Dyke, Chief Product Officer, Jeff Gartland, CEO  and Emily Tyson, Chief Operating Officer, all at Relatient are at the helm of these pathbreaking developments, tackling the enduring challenges in healthcare head-on. They discuss these development and more on this episode of Dash Talk.

Recent Episodes

Hospitals across the country are feeling the strain—too many open roles, not enough trained professionals, and a growing gap between what students learn and what the job actually demands on day one. Training is getting more expensive, timelines are stretching, and healthcare leaders are being forced to rethink how new clinicians enter the field….

In this episode of Care Anywhere, host Lea Sims sits down with Nigerian nurse entrepreneur and advocate Obafemi Arowosegbe to discuss leadership, mentorship, and the future of nursing in Africa. While still a nursing student, Obafemi founded the Nightingale Summit, a growing conference designed to empower nursing students and early-career nurses with leadership skills,…

The rapid expansion of precision medicine, biologics, and targeted cancer therapies is transforming oncology—but it’s also overwhelming a system not built to keep pace. In the U.S., cancer drugs now account for some of the highest-cost treatments in healthcare, and with that has come a surge in prior authorization requirements and denials. Studies suggest physicians…